Medical Devices

Image

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Feb 2023
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 103.80 Million
Diagram Market Size (Forecast Year) USD 174.39 Million
Diagram CAGR %

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market, By Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Tyrosinemia Types I and II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Acidemia, Disorders of Leucine Metabolism, Others), Form (Powder, Liquids, Others), Packaging (Can, Packets, Bottle, Jar, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Others) – Industry Trends and Forecast to 2030.

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Analysis and Size

For an individual with a particular genetic condition, nutritional therapy for inborn errors of metabolism meets between 85% and 90% of their nutritional needs. These supplements have negligible adverse effects, making them suitable for use by patients of all ages. Private medical insurance in the U.S. and a few other nations have recently started to provide reimbursement programmes for the use of specific medical foods. Therefore, the increasing adoption of medical foods and nutrient supplements enhances the market growth.  

Data Bridge Market Research analyses a growth rate in the medical foods for inborn errors of metabolism market in the forecast period 2023-2030. The expected CAGR of medical foods for inborn errors of metabolism market is tend to be around 6.70% in the mentioned forecast period. The market is valued at USD 103.8 million in 2022, and it would grow upto USD 174.39 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Products (Amino Acid, Low Protein Food, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Tyrosinemia Types I and II, Maple Syrup Urine Disease (MSUD), Homocystinuria, Glutaric Acidemia Type I, Urea Cycle Disorders, Methylmalonic Acidemia, Isovaleric Acidemia, Organic Acidurias, Renal Disease, Propionic Acidemia, Disorders of Leucine Metabolism, Others), Form (Powder, Liquids, Others), Packaging (Can, Packets, Bottle, Jar, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Others)

Countries Covered

Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

Market Players Covered

Nestlé Health Science (Switzerland), Nutricia (Netherlands), Solace Nutrition (U.S.), Abbott (U.S.), Mead Johnson andCompany, LLC.(U.S.), BioMarin Pharmaceutical (U.S.), Ajinomoto Cambrooke, Inc. (U.S.), Poa Pharma (Sweden), PKU-MDmil (U.S.), Dr.Schar AG/SPA Primus Pharmaceuticals, Inc. (Italy), Pristine Organics Pvt. Ltd. (India), APR (U.S.), Ener-G foods, INC (U.S.) and Promin Metabolics (U.K.)

Market Opportunities

  • Increased Product Launches and Agreements

Market Definition

Inborn metabolic errors are the type of disorders in which the body fails to convert food into energy. In case of inborn errors of metabolism, medical foods are widely used as treatment options, and the products accessible in the market are regulated under authoritative and regulatory food and diet supplement statuses. There is no specific enzyme production, which is mainly responsible for breaking down certain substances due to gene mutations.  

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Dynamics

Drivers

  • Increase in Preference for Dietary Supplements

Nutraceutical supplements and foods recommended for medicinal purposes are becoming increasingly popular than enzyme-based therapeutic medications. The inclination from medications to dietary supplements and medicinal foods is most likely because of increasing healthcare costs and customers' preference for inexpensive, quick, and efficient disease management methods. Therefore, this factor increases the growth of the market.

  • Increasing Use of Medical Foods

Medical foods are used as the ultimate treatment options for inborn metabolic errors, and the products available on the market are regulated under regulatory food and diet supplement statuses. The nutritional treatment for inherited metabolic errors meets between 85% and 90% of a person's nutritional needs. Additionally, these supplements have nearly no side effects, making them appropriate for patients of all age groups. Presently, private medical insurers in the U.S. and a few other countries have begun to provide reimbursement programmes for the consumption of certain medical foods. Therefore, increasing adoption of medical food and nutrient supplements is anticipated to boost the market growth during the forecast period 2023-2030. This factor improves the market growth.

Opportunities

  • Increased Product Launches and Agreements

There has been increasing product launches and agreements between market players,ncreasing the market's growth. For instance, Nutricia opened a sustainable plant in Netherlands in March 2019. The Nutricia Cuijk plant was a huge investment and has increased the volume of specialized infant formula and the market's revenue generation. Furthermore, in June, Mead Johnson andCompany, LLC. announced the merger with Reckitt Benckiser Group plc (RB).  It was anticipated that the Mead Johnson brand and business continued to grow with Reckitt Benckiser plc groups’ good innovation and marketing process. Thus, this factor created much opportunity for the market growth.  

Restraints/Challenges

  • Inadequate Reimbursement Policies

Even though several products were launched, but not all the products have been launched at a cheap price. An inadequate reimbursement scenario is anticipated to restrict the use of medical food and decrease the growth of the medical food market during the forecast period 2023-2030. Thus, this hampers the market growth.

This medical foods for inborn errors of metabolism market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medical foods for inborn errors of metabolism market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Scope

The medical foods for inborn errors of metabolism market is segmented on the basis of products, age group, diseases, form, packaging and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

  • Amino Acid
  • Glytactin with GMP Amino Acid-Modified Infant Formula with Iron
  • Low-Calcium/Vitamin D-Free Infant Formula with Iron
  • Low Protein Food
  • Others

 Age Group

  • Infants
  • Weaning
  • Adolescent
  • Adults

 Diseases

  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Homocystinuria
  • Methylmalonic Acidemia
  • Organic Acidurias
  • Propionic Acidemia
  • Isovaleric Acidemia
  • Disorders of Leucine Metabolism
  • Glutaric Acidemia Type I Renal Disease
  • Tyrosinemia Types I and II
  • Urea Cycle Disorders
  • Others

 Forms

  • Powder
  • Liquids
  • Gels and Others

 Packaging

  • Can
  • Jar
  • Packets
  • Bottle
  • Others

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Drugs Stores
  • Online Pharmacies
  • Others

Medical Foods for Inborn Errors of Metabolism Market Regional Analysis/Insights

The medical foods for inborn errors of metabolism market is analyzed and market size insights and trends are provided by mechanism, category, treatment, software, services, app accessibility, app type, application, patients as referenced above.

The major countries covered in the medical foods for inborn errors of metabolism market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Saudi Arabia is anticipated to grow with the highest CAGR in the forecast period because of increased healthcare expenditure in this region and patient are more shifted in taking medical food rather than enzymatic therapy. Disposable income is high through which it is feasible for the patients to afford the medical foods in their regular diet.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Share Analysis

The medical foods for inborn errors of metabolism market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to medical foods for inborn errors of metabolism market.

Key players operating in the medical foods for inborn errors of metabolism market include:

  • Nestlé Health Science (Switzerland)
  • Nutricia (Netherlands)
  • Solace Nutrition (U.S.)
  • Abbott (U.S.)
  • Mead Johnson andCompany, LLC.(U.S.)
  • BioMarin Pharmaceutical (U.S.)
  • Ajinomoto Cambrooke, Inc. (U.S.)
  • Poa Pharma (Sweden)
  • PKU-MDmil (U.S.)
  • Dr.Schar AG/SPA Primus Pharmaceuticals, Inc. (Italy)
  • Pristine Organics Pvt. Ltd. (India)
  • APR (U.S.)
  • Ener-G foods, INC (U.S.)
  • Promin Metabolics (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market will be worth USD 174.39 million by 2030 during the forecast period.
The Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market growth rate is 6.70% during the forecast period.
Increase in Preference for Dietary Supplements & Increasing Use of Medical Foods are the growth drivers of the Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market.
The products, age group, diseases, form, packaging and distribution channel are the factors on which the Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market research is based.
Nestlé Health Science (Switzerland), Nutricia (Netherlands), Solace Nutrition (U.S.), Abbott (U.S.), Mead Johnson andCompany, LLC.(U.S.), BioMarin Pharmaceutical (U.S.), Ajinomoto Cambrooke, Inc. (U.S.), Poa Pharma (Sweden), PKU-MDmil (U.S.), Dr.Schar AG/SPA Primus Pharmaceuticals, Inc. (Italy), Pristine Organics Pvt. Ltd. (India), APR (U.S.), Ener-G foods, INC (U.S.) and Promin Metabolics (U.K.) are the major companies in the Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials